These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37971525)

  • 1. [New treatment options in systemic therapy for breast cancer and associated new side effects].
    Landin J; Weber WP; Vetter M
    Ther Umsch; 2023 Oct; 80(8):353-358. PubMed ID: 37971525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in chemical pharmacotherapy to manage advanced breast cancer.
    Gombos A; Awada A
    Expert Opin Pharmacother; 2017 Jan; 18(1):95-103. PubMed ID: 27927046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic breast cancer: understanding current management options.
    McGinn K; Moore J
    Oncol Nurs Forum; 2001 Apr; 28(3):507-12; quiz 513-4. PubMed ID: 11338758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal management of brain metastases from breast cancer. Issues and considerations.
    Bartsch R; Berghoff AS; Preusser M
    CNS Drugs; 2013 Feb; 27(2):121-34. PubMed ID: 23239265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Implications of the Progression-Free Survival Endpoint for Treatment of Hormone Receptor-Positive Advanced Breast Cancer.
    Kaklamani VG
    Oncologist; 2016 Aug; 21(8):922-30. PubMed ID: 27256875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adjuvant therapies in breast carcinoma].
    Joss R; Brunner K
    Schweiz Rundsch Med Prax; 1991 Mar; 80(11):247-54. PubMed ID: 2024099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Taxanes in primary systemic treatment of breast cancer].
    von Minckwitz G
    Onkologie; 2003 Dec; 26 Suppl 7():21-5. PubMed ID: 14716138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adjuvant chemotherapy of early stage breast cancer].
    Boér K
    Orv Hetil; 2010 Feb; 151(9):344-53. PubMed ID: 20159750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
    Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
    Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metastases as site of first and isolated recurrence of breast cancer: the role of systemic therapy after local treatment.
    Niwińska A
    Clin Exp Metastasis; 2016 Oct; 33(7):677-85. PubMed ID: 27225754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trastuzumab-deruxtecan: an investigational agent for the treatment of HER2-positive breast cancer.
    Bartsch R
    Expert Opin Investig Drugs; 2020 Sep; 29(9):901-910. PubMed ID: 32701032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities.
    Jordan VC; Obiorah I; Fan P; Kim HR; Ariazi E; Cunliffe H; Brauch H
    Breast; 2011 Oct; 20 Suppl 3(Suppl 3):S1-11. PubMed ID: 22015273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer.
    Barrett SV
    J R Coll Physicians Edinb; 2010 Dec; 40(4):335-8; quiz 339. PubMed ID: 21132144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.
    Jankowitz RC; McGuire KP; Davidson NE
    Breast; 2013 Aug; 22 Suppl 2():S165-70. PubMed ID: 24074781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical management of early-stage breast cancer.
    Bookman MA; Goldstein LJ; Scher RM
    Curr Probl Cancer; 1991; 15(4):157-232. PubMed ID: 1874006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant systemic therapy for breast cancer: the Westmead experience.
    Cocco AM; Messer D; Brown A; Sriram N; Gilchrist J; Al-Mansouri L; Kefford R; Meybodi F; French J; Hsu J; Elder E
    ANZ J Surg; 2018 Jun; 88(6):640-644. PubMed ID: 28922685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy for breast cancer.
    Hortobagyi G
    Annu Rev Med; 2000; 51():377-92. PubMed ID: 10774471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Platinum-based chemotherapy in triple negative breast cancer].
    Eckstein N; Haas B
    Dtsch Med Wochenschr; 2012 Feb; 137(7):333-6. PubMed ID: 22318849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapeutics of capecitabine and trastuzumab in the treatment of metastatic breast cancer.
    McCauley S; Carter G; Bennett M; McNally O; Rogers KM
    Br J Nurs; 2020 Feb; 29(3):S4-S9. PubMed ID: 32053446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.